Richard Schwartz & Associates
Will Take Care of You & Your Claim
Mississippi Lawyers for Victims of Eye Damage & Vision Loss Caused by Elmiron®
Patients with interstitial cystitis (IC), a chronic bladder condition that causes painful inflammation and/or irritation, are often prescribed Elmiron®, a blood thinner and bladder protectant, to ease their symptoms. Devastatingly, Elmiron® has been found to cause pigmentary maculopathy, a degenerative eye disorder that could lead to vision changes, vision loss, and blindness.
At Richard Schwartz & Associates Injury Lawyers, P.A., we believe patients should never be put at such a life-changing risk without their knowledge. If you were injured as a result of taking Elmiron®, we invite you to call one of our award-winning attorneys. We have experience holding negligent corporations accountable; we want to fight for your right to compensation, as well as try to prevent others from being hurt in the same way.
Get the Facts: Elmiron®’s History and Harmful Side Effects
Elmiron®, pentosan polysulfate sodium, can only be obtained through a prescription from a medical professional. In the medical community, it is thought to be an effective treatment for bladder conditions, as it provides an extra coating of protection along the walls of the bladder. It is taken orally in the form of a pill and was first approved for use in 1996. In fact, it was initially thought to be so harmless that it was common to be prescribed Elmiron® as one of the first routes of treatment for IC.
Unfortunately, this prescription drug is now believed to be the cause behind some patients’ pigmentary maculopathy. For this reason, lawsuits against Elmiron®’s manufacturer, Janssen Pharmaceuticals, Inc., have flooded in. The reason? People are alleging that Janssen Pharmaceuticals, Inc. — a division of Johnson & Johnson — failed to warn patients of all of the dangers Elmiron® posed.
In fact, pigmentary maculopathy was not known to be an associated risk of the drug until 2015 when six different patients taking Elmiron® showed signs of this rare eye condition. These patients were all seen at the Emory Eye Center in Atlanta by doctors who had yet to encounter such a disorder. Both a 2018 study conducted by scientists and a 2019 study by the American Academy of Ophthalmology support the idea that Elmiron® causes maculopathy. Despite this, the drug is still approved by the United States Food and Drug Administration (FDA).
Do I Qualify for an Elmiron® Case?
If you are taking, or were previously taking, Elmiron® and are now experiencing one or more of the following signs of maculopathy, you may have a case:
- Change of color of the retina
- Dark spots in the middle of your vision
- Distorted vision, such as straight lines appearing curvy
- Colors appear less vivid
- Trouble reading
- Trouble adjusting to dim lighting
- Blurred vision
- Night blindness
We Are Here for Patients Injured by Elmiron®
For over three decades, our lawyers at Richard Schwartz & Associates have fought against negligence on behalf of injured individuals throughout Mississippi. All it takes is one call to speak to a member of our legal team recognized by the National Trial Lawyers, Super Lawyers®, and the American Association for Justice.
We know how hard it can be to go through a life-altering injury that is no fault of your own. That is why we value dependability, community, and communication as the pillars of our legal practice. If you are seeking honest, compassionate legal representation, Richard Schwartz & Associates is the firm for you.